Company Filing History:
Years Active: 2009-2010
Title: Anke Kebber: Innovator in Biochemical Engineering
Introduction
Anke Kebber is a prominent inventor based in Palo Alto, CA (US). She has made significant contributions to the field of biochemical engineering, particularly in the development of polypeptides with enhanced activity and stability. With a total of 2 patents, her work is paving the way for advancements in various biotechnological applications.
Latest Patents
Anke Kebber's latest patents include innovative inventions in the realm of glucose dehydrogenase and ketoreductase polypeptides. The first patent focuses on glucose dehydrogenase (GDH) polypeptides that exhibit enhanced GDH activity and/or thermostability compared to the wild-type glucose dehydrogenase polypeptide. This invention also encompasses polynucleotides that encode these GDH polypeptides, along with expression vectors and methods for producing them. The second patent pertains to variant polypeptides with improved ketoreductase activity and/or thermostability, aimed at the stereospecific reduction of ketones. This patent includes codon-optimized polynucleotides for enhanced expression in host cells, as well as nucleotide constructs and vectors.
Career Highlights
Anke Kebber is currently associated with Codexis, Inc., where she continues to innovate and contribute to the field of biotechnology. Her work has been instrumental in developing new methods and products that enhance biochemical processes.
Collaborations
Anke has collaborated with notable colleagues, including S Christopher Davis and Stephane J Jenne, to further her research and development efforts in the industry.
Conclusion
Anke Kebber's contributions to the field of biochemical engineering through her patents and collaborations highlight her role as a leading inventor. Her work continues to influence advancements in biotechnology and related fields.